Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications

被引：1

作者：

Low, En Xian Sarah ^{[1
]}

Wang, Yen-Po ^{[1
,3
]}

Lu, Ching-Liang ^{[1
,2
,3
]}

机构：

[1] Taipei Vet Gen Hosp, Endoscopy Ctr Diag & Treatment, Dept Med, Taipei, Taiwan

[2] Natl Yang Ming Chiao Tung Univ, Inst Brain Sci, Taipei, Taiwan

[3] Natl Yang Ming Chiao Tung Univ, Fac Med, Taipei, Taiwan

来源：

DIGESTIVE DISEASES AND SCIENCES | 2024年 / 69卷 / 01期

关键词：

Cirrhosis; Proton pump inhibitors; Hepatocellular carcinoma; Hepatic decompensation; Spontaneous bacterial peritonitis;

D O I：

10.1007/s10620-023-08153-3

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The use of proton pump inhibitor (PPI) in cirrhotic patients can be associated with increased risks of long-term mortality, decompensation, hepatic encephalopathy, spontaneous bacterial peritonitis, and infection, but not with short-term mortality. Ensure clear indications at lowest effective dose of is mandatory for the use of PPI among cirrhotic patients.

引用

页码：7 / 9

页数：3

共 50 条

[41] An update on oral antiplatelet drug interactions with proton pump inhibitors: what are the risks?
Jourdi, Georges
Hulot, Jean-Sebastien
Gaussem, Pascale
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (08) : 749 - 764
[42] The risks of long-term use of proton pump inhibitors: a critical review
Jaynes, Megan
Kumar, Avinash B.
THERAPEUTIC ADVANCES IN DRUG SAFETY, 2018, 10
[43] Proton pump inhibitors: Weighing the benefits and risks across various health conditions
Sizgoric, Luka
Likic, Robert
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (02) : 388 - 391
[44] Influence of proton pump inhibitors in the development of spontaneous bacterial peritonitis
Suelen A S Miozzo
Jorge A John
Marcelo C Appel-da-Silva
Isabella A Dossin
Cristiane V Tovo
Angelo A Mattos
World Journal of Hepatology, 2017, (35) : 1278 - 1285
[45] The impact of proton pump inhibitors in liver diseases and the effects on the liver
Liu, Yuan Bin
Chen, Ming Kai
JOURNAL OF DIGESTIVE DISEASES, 2022, 23 (04) : 196 - 208
[46] Proton Pump Inhibitor Use and Association with Spontaneous Bacterial Peritonitis in Patients with Cirrhosis and Ascites
Siple, Jolene F.
Morey, Jessica M.
Gutman, Tracy E.
Weinberg, Kathy L.
Collins, Peggie D.
ANNALS OF PHARMACOTHERAPY, 2012, 46 (10) : 1413 - 1418
[47] Hypomagnesemia in Hemodialysis Patients:Role of Proton Pump Inhibitors
Alhosaini, Mohamad
Walter, James S.
Singh, Sanjay
Dieter, Robert S.
Hsieh, Annming
Leehey, David J.
AMERICAN JOURNAL OF NEPHROLOGY, 2014, 39 (03) : 204 - 209
[48] Indications and safety of proton pump inhibitor drug use in patients with cancer
Triadafilopoulos, George
Roorda, Andrew K.
Akiyama, Junichi
EXPERT OPINION ON DRUG SAFETY, 2013, 12 (05) : 659 - 672
[49] Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis
Kwon, Jee Hye
Koh, Seong-Joon
Kim, Won
Jung, Yong Jin
Kim, Ji Won
Kim, Byeong Gwan
Lee, Kook Lae
Im, Jong Pil
Kim, Yoon Jun
Kim, Joo Sung
Yoon, Jung-Hwan
Lee, Hyo-Suk
Jung, Hyun Chae
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (04) : 775 - 781
[50] Proton Pump Inhibitors Increase the Incidence of Bone Fractures in Hepatitis C Patients
Mello, Michael
Weideman, Rick A.
Little, Bertis B.
Weideman, Mark W.
Cryer, Byron
Brown, Geri R.
DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (09) : 2416 - 2422

← 1 2 3 4 5 →